+ All Categories
Home > Documents > Monitoring of medical literature and the entry of relevant ... · Monitoring of medical literature...

Monitoring of medical literature and the entry of relevant ... · Monitoring of medical literature...

Date post: 14-Oct-2019
Category:
Upload: others
View: 8 times
Download: 0 times
Share this document with a friend
373
30 Churchill Place Canary Wharf London E14 5EU United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged. 23 October 2015 EMA/517840/2015 Rev 1* Inspections and Human Medicines Pharmacovigilance Division Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency EMBASE Search Strategies for Substance Groups 1-300, and Herbal Substance Groups 1-100 *Note: Revision 1 includes the following: Content amended subsequent to ‘Launch Phase’ findings. Individual search strategy for EMBASE is defined, previously one document covered both EMBASE and EBSCO searches. The EBSCO search strategy is defined in a separate document published on the MLM website (EMA/698804/2015).
Transcript
  • 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom

    An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact

    © European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged.

    23 October 2015 EMA/517840/2015 Rev 1* Inspections and Human Medicines Pharmacovigilance Division

    Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency EMBASE Search Strategies for Substance Groups 1-300, and Herbal Substance Groups 1-100

    *Note: Revision 1 includes the following: Content amended subsequent to ‘Launch Phase’ findings. Individual search strategy for EMBASE is defined, previously one document covered both EMBASE and EBSCO searches. The EBSCO search strategy is defined in a separate document published on the MLM website (EMA/698804/2015).

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 2/373

    Table of Contents

    I. Introduction ......................................................................................... 12

    II. General Principles ............................................................................... 12

    III. Search parameters for chemical substance groups and variants ....... 14 1. Paracetamol ....................................................................................................... 14 2. Hydrochlorothiazide ............................................................................................. 20 3. Ibuprofen ........................................................................................................... 29 4. Omeprazole ........................................................................................................ 32 5. Amlodipine ......................................................................................................... 33 6. Simvastatin ........................................................................................................ 36 7. Diclofenac .......................................................................................................... 37 8. Ciprofloxacin ...................................................................................................... 39 9. Pantoprazole ...................................................................................................... 41 10. Lidocaine .......................................................................................................... 42 11. Sodium Chloride ................................................................................................ 45 12. Fluconazole ...................................................................................................... 51 13. Montelukast ...................................................................................................... 52 14. Atorvastatin ...................................................................................................... 53 15. Acetylsalicylic Acid ............................................................................................. 55 16. Amoxicillin ........................................................................................................ 58 17. Donepezil ......................................................................................................... 59 18. Ethinylestradiol ................................................................................................. 60 19. Losartan........................................................................................................... 65 20. Olanzapine ....................................................................................................... 66 21. Clopidogrel ....................................................................................................... 67 22. Risperidone ...................................................................................................... 68 23. Tamsulosin ....................................................................................................... 69 24. Aciclovir ........................................................................................................... 70 25. Azithromycin .................................................................................................... 71 26. Levofloxacin ..................................................................................................... 72 27. Finasteride ....................................................................................................... 73 28. Alendronic acid ................................................................................................. 74 29. Valsartan ......................................................................................................... 75 30. Clarithromycin .................................................................................................. 76 31. Venlafaxine ...................................................................................................... 77 32. Cetirizine .......................................................................................................... 78 33. Sertraline ......................................................................................................... 80 34. Ramipril ........................................................................................................... 81 35. Calcium Carbonate ............................................................................................ 81 36. Sildenafil .......................................................................................................... 83 37. Ascorbic Acid .................................................................................................... 84 38. Levetiracetam ................................................................................................... 86

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 3/373

    39. Hydrocortisone.................................................................................................. 87 40. Terbinafine ....................................................................................................... 89 41. Anastrozole ...................................................................................................... 90 42. Citalopram ....................................................................................................... 90 43. Ranitidine ......................................................................................................... 91 44. Metformin ........................................................................................................ 93 45. Lansoprazole .................................................................................................... 94 46. Fluoxetine ........................................................................................................ 95 47. Tramadol ......................................................................................................... 96 48. Letrozole .......................................................................................................... 97 49. Escitalopram ..................................................................................................... 98 50. Esomeprazole ................................................................................................... 99 51. Bicalutamide ................................................................................................... 100 52. Gabapentin ..................................................................................................... 101 53. Fentanyl ......................................................................................................... 102 54. Quetiapine ...................................................................................................... 102 55. Cefuroxime ..................................................................................................... 103 56. Paroxetine ...................................................................................................... 104 57. Enalapril......................................................................................................... 105 58. Indapamide .................................................................................................... 106 59. Ondansetron ................................................................................................... 108 60. Candesartan ................................................................................................... 109 61. Risedronic Acid ............................................................................................... 110 62. Pravastatin ..................................................................................................... 111 63. Glimepiride ..................................................................................................... 112 64. Lisinopril ........................................................................................................ 112 65. Carvedilol ....................................................................................................... 113 66. Timolol........................................................................................................... 114 67. Latanoprost .................................................................................................... 115 68. Salicylic Acid ................................................................................................... 116 69. Metronidazole ................................................................................................. 118 70. Budesonide .................................................................................................... 119 71. Dexamethasone .............................................................................................. 120 72. Topiramate ..................................................................................................... 122 73. Bisoprolol ....................................................................................................... 122 74. Atenolol ......................................................................................................... 123 75. Furosemide .................................................................................................... 124 76. Prednisolone ................................................................................................... 125 77. Irbesartan ...................................................................................................... 127 78. Ambroxol ....................................................................................................... 127 79. Lamotrigine .................................................................................................... 129 80. Mirtazapine .................................................................................................... 129 81. Ceftriaxone ..................................................................................................... 130 82. Acetylcysteine ................................................................................................. 131

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 4/373

    83. Meloxicam ...................................................................................................... 132 84. Ropinirole ....................................................................................................... 133 85. Memantine ..................................................................................................... 134 86. Loratidine ....................................................................................................... 135 87. Zoledronic Acid ............................................................................................... 136 88. Zolpidem ........................................................................................................ 137 89. Nebivolol ........................................................................................................ 137 90. Chlorhexidine.................................................................................................. 138 91. Gemcitabine ................................................................................................... 139 92. Ibandronic Acid ............................................................................................... 140 93. Clindamycin .................................................................................................... 141 94. Betamethasone ............................................................................................... 142 95. Salbutamol ..................................................................................................... 143 96. Naproxen ....................................................................................................... 144 97. Desloratadine ................................................................................................. 145 98. Exemestane .................................................................................................... 146 99. Ketoprofen ..................................................................................................... 147 100. Rivastigmine ................................................................................................. 148 101. Glyceryl Trinitrate .......................................................................................... 149 102. Piperacillin .................................................................................................... 150 103. Doxazosin ..................................................................................................... 151 104. Estradiol ....................................................................................................... 152 105. Metoprolol .................................................................................................... 153 106. Morphine ...................................................................................................... 154 107. Isosorbide .................................................................................................... 155 108. Loperamide .................................................................................................. 156 109. Telmisartan .................................................................................................. 157 110. Glucose ........................................................................................................ 158 111. Rabeprazole .................................................................................................. 160 112. Oxaliplatin .................................................................................................... 160 113. Colecalciferol ................................................................................................ 161 114. Gliclazide ...................................................................................................... 162 115. Lactulose ...................................................................................................... 163 116. Pramipexole .................................................................................................. 164 117. Alprazolam ................................................................................................... 164 118. Diltiazem ...................................................................................................... 165 119. Alfuzosin ...................................................................................................... 166 120. Fluticasone Propionate ................................................................................... 167 121. Formoterol .................................................................................................... 168 122. Levocitirizine ................................................................................................. 169 123. Betahistine ................................................................................................... 170 124. Dextromethorphan ........................................................................................ 171 125. Irinotecan ..................................................................................................... 172 126. Ceftazidime .................................................................................................. 173

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 5/373

    127. Lercanidipine ................................................................................................ 173 128. Paclitaxel ...................................................................................................... 174 129. Xylometazoline .............................................................................................. 175 130. Epinephrine .................................................................................................. 176 131. Piroxicam ..................................................................................................... 178 132. Potassium Chloride ........................................................................................ 178 133. Sumatriptan ................................................................................................. 180 134. Perindopril .................................................................................................... 180 135. Doxycycline .................................................................................................. 181 136. Glucosamine ................................................................................................. 182 137. Itraconazole .................................................................................................. 183 138. Captopril ...................................................................................................... 184 139. Codeine ........................................................................................................ 185 140. Fluvastatin .................................................................................................... 186 141. Meropenem .................................................................................................. 186 142. Docetaxel ..................................................................................................... 187 143. Allopurinol .................................................................................................... 187 144. Domperidone ................................................................................................ 188 145. Mometasone ................................................................................................. 189 146. Mycophenolic Acid ......................................................................................... 190 147. Amiodarone .................................................................................................. 190 148. Cyanocobalamin ............................................................................................ 191 149. Epirubicin ..................................................................................................... 192 150. Galantamine ................................................................................................. 193 151. Valaciclovir ................................................................................................... 193 152. Celecoxib ...................................................................................................... 194 153. Nifedipine ..................................................................................................... 194 154. Vancomycin .................................................................................................. 195 155. Zolmitriptan .................................................................................................. 196 156. Moxifloxacin .................................................................................................. 196 157. Diazepam ..................................................................................................... 197 158. Erythromycin ................................................................................................ 198 159. Folinic Acid ................................................................................................... 199 160. Glycerol........................................................................................................ 200 161. Carbidopa ..................................................................................................... 201 162. Cromoglicic Acid ............................................................................................ 202 163. Heparin ........................................................................................................ 203 164. Oxygen ........................................................................................................ 204 165. Zinc Oxide .................................................................................................... 204 166. Ketoconazole ................................................................................................ 206 167. Ofloxacin ...................................................................................................... 206 168. Folic Acid ...................................................................................................... 207 169. Progesterone ................................................................................................ 209 170. Sodium Hydrogen Carbonate .......................................................................... 210

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 6/373

    171. Triamcinolone ............................................................................................... 211 172. Nimesulide.................................................................................................... 212 173. Cefotaxime ................................................................................................... 213 174. Gentamicin ................................................................................................... 214 175. Lorazepam.................................................................................................... 214 176. Granisetron .................................................................................................. 215 177. Pioglitazone .................................................................................................. 216 178. Amisulpride .................................................................................................. 216 179. Clotrimazole ................................................................................................. 217 180. Remifentanil ................................................................................................. 218 181. Spironolactone .............................................................................................. 218 182. Tacrolimus .................................................................................................... 219 183. Dorzolamide ................................................................................................. 220 184. Rosuvastatin ................................................................................................. 220 185. Midazolam .................................................................................................... 221 186. Verapamil ..................................................................................................... 221 187. Bromazepam ................................................................................................ 222 188. Bromhexine .................................................................................................. 223 189. Carbocisteine ................................................................................................ 224 190. Isotretinoin ................................................................................................... 225 191. Ticlopidine .................................................................................................... 225 192. Tobramycin................................................................................................... 226 193. Metamizole ................................................................................................... 227 194. Rizatriptan .................................................................................................... 228 195. Valproic Acid ................................................................................................. 228 196. Capecitabine ................................................................................................. 229 197. Desogestrel .................................................................................................. 230 198. Metoclopramide ............................................................................................. 230 199. Repaglinide ................................................................................................... 231 200. Tolterodine ................................................................................................... 232 201. Ribavirin ....................................................................................................... 232 202. Mesalazine .................................................................................................... 233 203. Oxycodone ................................................................................................... 234 204. Beclometasone .............................................................................................. 234 205. Carbamazepine ............................................................................................. 235 206. Eplerenone ................................................................................................... 236 207. Fenofibrate ................................................................................................... 236 208. Somatropin ................................................................................................... 237 209. Trimetazidina ................................................................................................ 238 210. Bisacodyl ...................................................................................................... 238 211. Buprenorphine .............................................................................................. 239 212. Oxybutynin ................................................................................................... 240 213. Tamoxifen .................................................................................................... 240 214. Zopiclone ..................................................................................................... 241

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 7/373

    215. Brimonidine .................................................................................................. 242 216. Cisatracurium Besilate.................................................................................... 242 217. Mikonazol ..................................................................................................... 243 218. Roxithromycin ............................................................................................... 243 219. Simeticone ................................................................................................... 244 220. Cilastatin ...................................................................................................... 245 221. Indometacin ................................................................................................. 245 222. Piracetam ..................................................................................................... 246 223. Theophylline ................................................................................................. 247 224. Sotalol ......................................................................................................... 248 225. Felodipine ..................................................................................................... 248 226. Norfloxacin ................................................................................................... 249 227. Atropine ....................................................................................................... 250 228. Bupivacaine .................................................................................................. 250 229. Carboplatin ................................................................................................... 251 230. Doxorubicin .................................................................................................. 252 231. Famotidine ................................................................................................... 252 232. Methotrexate ................................................................................................ 253 233. Quinapril ...................................................................................................... 254 234. Ropivacaine Hydrochloride .............................................................................. 254 235. Benazalkonium .............................................................................................. 255 236. Flecainide ..................................................................................................... 256 237. Povidone, Iodinated ....................................................................................... 256 238. Testosterone ................................................................................................. 257 239. Cefaclor ....................................................................................................... 258 240. Nicotine ........................................................................................................ 258 241. Oxymetazoline .............................................................................................. 259 242. Cefixime ....................................................................................................... 260 243. Ciclopirox ..................................................................................................... 260 244. Minoxidil ....................................................................................................... 261 245. Pentoxifylline ................................................................................................ 261 246. Tocopherol.................................................................................................... 262 247. Ampicillin ..................................................................................................... 263 248. Lormetazepam .............................................................................................. 264 249. Alprostadil .................................................................................................... 264 250. Amorolfine .................................................................................................... 265 251. Levothyroxine ............................................................................................... 265 252. Moxonidine ................................................................................................... 266 253. Nitrous Oxide ................................................................................................ 267 254. Linezolid ....................................................................................................... 267 255. Lovastatin .................................................................................................... 268 256. Sulpiride ....................................................................................................... 269 257. Tetracycline .................................................................................................. 269 258. Naratriptan ................................................................................................... 270

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 8/373

    259. Phenylephrine ............................................................................................... 270 260. Acarbose ...................................................................................................... 271 261. Amitriptyline ................................................................................................. 272 262. Retinol Acetate .............................................................................................. 272 263. Terazosin ..................................................................................................... 274 264. Ziprasidone................................................................................................... 274 265. Clozapine ..................................................................................................... 275 266. Flumazenil .................................................................................................... 275 267. Glibenclamide ............................................................................................... 276 268. Levonorgestrel .............................................................................................. 276 269. Magnesium Sulfate ........................................................................................ 277 270. Octreotide .................................................................................................... 278 271. Propofol ....................................................................................................... 278 272. Vinorelbine ................................................................................................... 279 273. Etoposide ..................................................................................................... 280 274. Oxcarbazepine .............................................................................................. 280 275. Propanolol Hydrochloride ................................................................................ 281 276. Alfaclcidol ..................................................................................................... 281 277. Flutamide ..................................................................................................... 282 278. Fosmycin ...................................................................................................... 283 279. Leuprorelin ................................................................................................... 283 280. Azathioprine ................................................................................................. 284 281. Co-Trimoxazole ............................................................................................. 285 282. Torasemide ................................................................................................... 285 283. Chloramphenicol ............................................................................................ 286 284. Clobatesol .................................................................................................... 287 285. Mannitol ....................................................................................................... 287 286. Methylphenidate Hydrochloride ....................................................................... 288 287. Paricalcitol .................................................................................................... 289 288. Aceclofenac .................................................................................................. 289 289. Cisplatin ....................................................................................................... 290 290. Diosmin ........................................................................................................ 290 291. Amikacin ...................................................................................................... 291 292. Cefazolin ...................................................................................................... 292 293. Haloperidol ................................................................................................... 292 294. Nitrazepam ................................................................................................... 293 295. Ursodeoxycholic acid ...................................................................................... 293 296. Salcatonin .................................................................................................... 294 297. Ciclosporin .................................................................................................... 295 298. Fexofenadine ................................................................................................ 295 299. 5-Fluorouracil................................................................................................ 296 300. Fosinopril ..................................................................................................... 297

    IV. Search parameters for herbal substance groups and variants .......... 298 301. Valeriana ...................................................................................................... 298

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 9/373

    302. Hypericum .................................................................................................... 300 303. Eucalyptus .................................................................................................... 301 304. Mentha ......................................................................................................... 303 305. Plantago ....................................................................................................... 305 306. Echinacea ..................................................................................................... 306 307. Senna .......................................................................................................... 308 308. Thymus ........................................................................................................ 309 309. Crategus ...................................................................................................... 310 310. Serenoa ....................................................................................................... 311 311. Silybum ........................................................................................................ 312 312. Soya ............................................................................................................ 313 313. Arnica .......................................................................................................... 315 314. Ginkgo ......................................................................................................... 316 315. Matricaria ..................................................................................................... 317 316. Cimicfuga ..................................................................................................... 318 317. Aesculus ....................................................................................................... 319 318. Ipecacuanha ................................................................................................. 321 319. Urtica ........................................................................................................... 321 320. Ginseng ........................................................................................................ 322 321. Hedera ......................................................................................................... 324 322. Cynara ......................................................................................................... 325 323. Atropa .......................................................................................................... 326 324. Linum .......................................................................................................... 327 325. Betula .......................................................................................................... 327 326. Capsicum ..................................................................................................... 328 327. Hamamelis ................................................................................................... 329 328. Harpagophytum ............................................................................................ 330 329. Calendula ..................................................................................................... 330 330. Salvia .......................................................................................................... 331 331. Avena .......................................................................................................... 332 332. Passiflora ...................................................................................................... 333 333. Artemisia ...................................................................................................... 333 334. Melissa ......................................................................................................... 334 335. Vitex ............................................................................................................ 335 336. Equisteum .................................................................................................... 335 337. Ricinus ......................................................................................................... 336 338. Phleum......................................................................................................... 337 339. Sambucus .................................................................................................... 338 340. Taraxacum ................................................................................................... 339 341. Viscum ......................................................................................................... 340 342. Citrus ........................................................................................................... 340 343. Corylus ........................................................................................................ 342 344. Gentiana ...................................................................................................... 342 345. Solanum ....................................................................................................... 343

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 10/373

    346. Turpentine .................................................................................................... 343 347. Alternaria ..................................................................................................... 344 348. Chelidonium .................................................................................................. 345 349. Salix ............................................................................................................ 345 350. Symphytum .................................................................................................. 346 351. Ambrosia ...................................................................................................... 346 352. Arctostaphylos .............................................................................................. 347 353. Cassia .......................................................................................................... 347 354. Quercus ....................................................................................................... 348 355. Tilia ............................................................................................................. 348 356. Fagus ........................................................................................................... 349 357. Juglans ........................................................................................................ 349 358. Niaouli ......................................................................................................... 350 359. Parietaria ..................................................................................................... 350 360. Dactylis ........................................................................................................ 351 361. Solidaginis .................................................................................................... 351 362. Vaccinium ..................................................................................................... 352 363. Vitis ............................................................................................................. 352 364. Camellia ....................................................................................................... 353 365. Cascara ........................................................................................................ 353 366. Fraxinus ....................................................................................................... 354 367. Hordeum ...................................................................................................... 354 368. Rhamnus ...................................................................................................... 355 369. Syzygium ..................................................................................................... 356 370. Veratrum ...................................................................................................... 356 371. Verbascum ................................................................................................... 357 372. Aloe ............................................................................................................. 357 373. Apium .......................................................................................................... 358 374. Curcuma ...................................................................................................... 358 375. Pelagonium ................................................................................................... 359 376. Strophantus .................................................................................................. 359 377. Anacardium .................................................................................................. 360 378. Centella........................................................................................................ 360 379. Erysimum ..................................................................................................... 361 380. Prunus ......................................................................................................... 361 381. Ulmus .......................................................................................................... 361 382. Viola ............................................................................................................ 362 383. Chenopodium ................................................................................................ 362 384. Citronella ...................................................................................................... 363 385. Daucus ......................................................................................................... 363 386. Garlic ........................................................................................................... 364 387. Ginger .......................................................................................................... 364 388. Origanum ..................................................................................................... 365 389. Rhubarb ....................................................................................................... 365

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 11/373

    390. Althaea ........................................................................................................ 366 391. Anise ........................................................................................................... 366 392. Cucurbita ..................................................................................................... 367 393. Orthosiphon .................................................................................................. 367 394. Pygeum ........................................................................................................ 368 395. Justicia ......................................................................................................... 368 396. Lavandula ..................................................................................................... 369 397. Oenothera .................................................................................................... 369 398. Ruscus ......................................................................................................... 370 399. Angelica ....................................................................................................... 370 400. Illicium ......................................................................................................... 371

    V. Safety string versions ........................................................................ 372

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 12/373

    I. Introduction

    The operation of the full MLM service started on 1 September 2015 and covers active chemical substance groups 1-300, and herbal substance groups 1-100. The substance groups are published at the dedicated MLM webpage “Medical literature monitoring: substance and herbal substance groups”.

    This document outlines the search strategy for each of the substance groups as part of the Agency’s activities set out in Article 27 of Regulation (EC) 726/2014 used to undertake the daily search in EMBASE. Please note that ‘daily’ refers to calendar days with the exception of weekends (Saturday and Sunday).

    The search strategy was created in EMBASE and uses the syntax and terminology of the EMBASE search engine.

    II. General Principles • The search for each substance group has been prepared to be exhaustive in line with the

    requirements of GVP module VI, chapter VI.App2.3.2.

    • The most comprehensive search strategy targeted to achieve precise results as regards the areas

    to be monitored have been defined for each substance group and for the literature reference

    databases as outlined in the description of the journal/reference databases used as published at

    the dedicated MLM webpage.

    • The search parameters aim to identify and retrieve:

    − suspected adverse reactions originating from spontaneous reports and solicited reports in

    humans (see GVP module VI, chapter VI.B.1.1. and VI.B.1.2.) and

    − special situations such as lack of therapeutic efficacy, use of a medicinal product during

    pregnancy and breastfeeding, use of a medicinal product in a paediatric or elderly population,

    reports of off-label use, misuse, abuse, overdose, medication error as well as occupational

    exposure associated with suspected adverse reactions.

    The exact scope is defined in the “Detailed guide regarding the monitoring of medical literature

    and the entry of relevant information into the EudraVigilance database by the European

    Medicines Agency” (hereafter referred to as “Detailed Guide”).

    • Each search strategy is routinely reviewed and updated where necessary to improve search

    precision or to align with any updates to the thesaurus used for indexing in the journal/reference

    databses used.

    − The first update to the safety filter was made on 01 October 2015. The previous version is

    contained in Chapter IV: Search string versions

    • Each search strategy is applied to the journal/reference databases according to the predefined

    periodicity as outlined in the Detailed Guide.

    • Each search is conducted with a “human” filter and is limited to articles published after 1 January

    2015.

    http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500186735http://www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500186732http://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/05/WC500186731.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/05/WC500186731.pdfhttp://www.ema.europa.eu/docs/en_GB/document_library/Other/2015/05/WC500186731.pdf

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 13/373

    − Searching is performed without enabling language filters to retrieve all articles that meet the

    search criteria.

    • The search strategy for each substance group is constituted of multiple components such as the

    International Nonproprietary Name (INN) as well as alternative names (variants) for the

    substances based on the information available in the Extended EudraVigilance Medicinal Product

    Dictionary (xEVMPD).

    Alternative names include medicinal product names (brand names) based on the information

    submitted by marketing authorisation holders in accordance with Article 57(2), second

    subparagraph of Regulation (EC) 726/2004 as well as variants for medicinal product names that

    have been reported in ICSRs to EudraVigilance.

    • The additional core search strategy applied in order to increase the precision of the search in each

    active substance group in Boolean format is as follows:

    AND 'adverse drug reaction'/exp OR adverse:de,ab,ti OR 'side effect':de,ab,ti OR 'side effects':de,ab,ti OR 'side effect':lnk OR 'drug overdose'/exp OR overdos*:de,ab,ti OR 'drug misuse'/exp OR misus*:de,ab,ti OR 'drug abuse'/exp OR 'substance abuse'/exp OR abus*:de,ab,ti OR 'pregnancy'/exp OR pregnan*:de,ab,ti OR 'pregnancy complications'/exp OR 'lactation'/exp OR 'breast feeding'/exp OR ('milk human'/exp AND 'secretion'/exp) OR 'fertility'/exp OR 'reproduction'/exp OR 'fetus'/exp OR 'embryo'/exp OR terat*:de,ab,ti OR 'drug efficacy'/exp OR 'drug withdrawal'/exp OR 'medication error'/exp OR 'death'/exp OR death*:de,ab,ti OR fatal*:de,ab,ti OR 'drug interactions'/exp OR 'drug interaction'/exp OR 'carcinogenicity'/exp OR carcinogen*:de,ab,ti OR mutagen*:de,ab,ti OR 'off label drug use'/exp OR 'occupational exposure'/exp OR 'toxicity'/exp OR toxic*:de,ab,ti OR pharmacotox*:de,ab,ti OR neurotox*:de,ab,ti OR cardiotox*:de,ab,ti OR nephrotox*:de,ab,ti OR immunotox*:de,ab,ti OR hepatotox*:de,ab,ti OR cytotox*:de,ab,ti OR immunocytotox*:de,ab,ti OR 'intoxication'/exp OR 'congenital disorder'/exp OR 'drug treatment failure'/exp OR 'case report'/exp OR 'case reports':de,ab,ti OR 'environmental exposure'/exp OR 'treatment contraindication'/exp OR 'drug contraindication'/exp OR 'injury'/exp OR suicide:de,ab,ti OR 'poisoning'/exp OR 'drug tolerance'/exp/mj OR 'treatment failure'/exp/mj OR 'drug resistance'/exp/mj OR 'substance-related disorders'/exp OR 'treatment failure'/exp OR 'drug resistance'/exp OR 'drug resistance':lnk) AND [humans]/lim Search string glossary:

    *: wildcard – anything following that string

    ab: abstract

    de: index term

    lim: limiter

    lnk: subheading

    mj: major focus of article

    ti: article title

    The term ‘adverse drug reaction’ is linked to the term adverse event in the literature reference database thesaurus. Other terms linked to ADR and therefore not called out as specific search terms include absence of side effects, antibiotic associated diarrhoea, application site reaction +, chemotherapy induced emesis, contrast induced nephropathy, corticosteroid induced myopathy, corticosteroid induced osteoporosis, drug eruption +, drug fatality, drug fever, drug hypersensitivity +, drug induced disease, drug induced headache, flu like syndrome, hand foot syndrome, heparin induced thrombocytopenia, HIV associated lipodystrophy, Injection site

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 14/373

    reaction +, instillation site reaction, neuroleptic induced deficit syndrome, neuroleptic malignant syndrome, opioid induced emesis, paradoxical drug reaction, procedural site reaction, propofol infusion syndrome, retinoic acid syndrome, serotonin syndrome, tumor flare, tumor lysis syndrome, unspecified side effect, vaccination reaction. (+ = exploded terms used as well).

    III. Search parameters for chemical substance groups and variants

    1. Paracetamol

    ‘PARACETAMOL’ OR ‘ACETAMINOPHEN’ OR ‘PARACETAMOLA’ OR ‘PARACETAMOLU’ OR ‘PARACETAMOLS’ OR ‘PARACETAMOLA’ OR ‘PARACETAMOLIS’ OR ‘PARACETAMOLUM’ OR ‘ACETAMINOFENE’ OR ‘PARACETAMOLO’ OR ‘PARASETAMÓLI’ OR ‘PARACETAMOLT’ OR ‘PARAICÉITAMÓL’ OR ‘PARACÉTAMOL’ OR ‘PARASETAMOLI’ OR ‘PARASETAMOLIA’ OR ‘PARATSETAMOOLI’ OR ‘PARATSETAMOOL’ OR ‘PARACETAMOLUM’ OR ‘24 HOUR COLD & FLU RELIEF’:tn OR ‘ABALON’:tn OR ‘ACECLOFEN’:tn OR ‘ACENOL’:tn OR ‘ACETAMOL’:tn OR ‘ACIFEIN’:tn OR ‘ACTIFEDSIGN’:tn OR ‘ACTIGRIP’:tn OR ‘ACTRON’:tn OR ‘ACUTRAL’:tn OR ‘ADALGUR’:tn OR ‘ADOLEF’:tn OR ‘ADOLOMED’:tn OR ‘ADOLORIN’:tn OR ‘ADOREA’:tn OR ‘AFEBRYL’:tn OR ‘AJUTA COLD & FLU LEMON FLAVOUR’:tn OR ‘AJUTA MAX STRENGTH COLD & FLU LEMON FLAVOUR’:tn OR ‘ALBERT HEIJN PARACETAMOL’:tn OR ‘ALBERT HEIJN PARACETAMOLCOFFEINE’:tn OR ‘ALERGICAL EXPECTORANTE’:tn OR ‘ALGASYN’:tn OR ‘ALGICALM’:tn OR ‘ALGIDOL’:tn OR ‘ALGINE’:tn OR ‘ALGISEDAL’:tn OR ‘ALGOCALM’:tn OR ‘ALGOCID’:tn OR ‘ALGOCIT’:tn OR ‘ALGODOL’:tn OR ‘ALGOFEN’:tn OR ‘ALGON’:tn OR ‘ALGOPARA’:tn OR ‘ALGOPIRIN’:tn OR ‘ALGOPIRINA’:tn OR ‘ALGOSTASE’:tn OR ‘ALGOTRA’:tn OR ‘ALGOTROPYL’:tn OR ‘ALKASELTZER XS’:tn OR ‘ALMIGRIPE’:tn OR ‘ALVEDON’:tn OR ‘ALVEDON DOS’:tn OR ‘ALVEDON FORTE’:tn OR ‘ALVEDON NOVUM’:tn OR ‘ALVEDON SUPPOSITORIES’:tn OR ‘ANADIN’:tn OR ‘ANADIN EXTRA’:tn OR ‘ANALGILASA’:tn OR ‘ANALGIPLUS’:tn OR ‘ANALGISER’:tn OR ‘ANTICATARRAL’:tn OR ‘ANTIDOL’:tn OR ‘ANTIGRIPAL’:tn OR ‘ANTIGRIPPINE’:tn OR ‘ANTINEVRALGIC’:tn OR ‘ANTIREUMINA’:tn OR ‘APAMOL’:tn OR ‘APAP’:tn OR ‘APAP, VAIKAMS’:tn OR ‘APC’:tn OR ‘APIREDOL’:tn OR ‘APIRETAL’:tn OR ‘APOTRAMADOLPARACETAMOL’:tn OR ‘APOGRIP’:tn OR ‘APOPATRAM’:tn OR ‘APOTEL’:tn OR ‘ARAX’:tn OR ‘ARFEN’:tn OR ‘ASCOPHEN P’:tn OR ‘ASCORBIC ACIDPARACETAMOL ’:tn OR ‘ASKOFENAS’:tn OR ‘ASPACO’:tn OR ‘ASPIRINPARACETAMOLCAFFEINE WOCKHARDT UK LTD’:tn OR ‘ATARALGIN’:tn OR ‘ATRALIDON’:tn OR ‘AUROGRIP’:tn OR ‘AZUR’:tn OR ‘BABY RINOLO’:tn OR ‘BANIMAX’:tn OR ‘BEECHAMS’:tn OR ‘BEECHAMS COLD & FLU’:tn OR ‘BEECHAMS COLD RELIEF’:tn OR ‘BEECHAMS FLUPLUS’:tn OR ‘BEECHAMS HOT LEMON’:tn OR ‘BEECHAMS MAX STRENGTH ALL IN ONE’:tn OR ‘BEECHAMS ULTRA ALL IN ONE’:tn OR ‘BEECHAMS WARMERS LEMON’:tn OR ‘BENURON’:tn OR ‘BENE DIREKT’:tn OR ‘BIOFLU’:tn OR ‘BISOLGRIP’:tn OR ‘BLACKCURRANT COLDREX’:tn OR ‘BOLOPAX’:tn OR ‘BOOTS CAPSULES’:tn OR ‘BOOTS PARACETAMOL CAPLETS’:tn OR ‘BOXAZIN’:tn OR ‘BRILIVO’:tn OR ‘BUSCAPINA PLUS’:tn OR ‘BUSCOPAN COMPOSITUM’:tn OR ‘BUSCOPAN PLUS’:tn OR ‘C1000 KINDERPARACETAMOL’:tn OR ‘C1000 PARACETAMOL COFFEINE’:tn OR ‘CAFCOLD’:tn OR ‘CAFFEINEPARACETAMOL PCH’:tn OR ‘CAFFETIN’:tn OR ‘CALEFRED’:tn OR ‘CALMAGRIP’:tn OR ‘CALPOL’:tn OR ‘CARE INFANT PARACETAMOL’:tn OR ‘CEBIOPIRINA’:tn OR ‘CEFALGIN’:tn OR ‘CEFALINE HAUTH’:tn OR ‘CERUGRIP’:tn OR ‘CETEBE ANTIGRIPPAL ERKÄLTUNGSTRUNK FORTE’:tn OR ‘CETEBE DUOEFFEKT ERKÄLTUNGSTRUNK’:tn OR ‘CETEBE DUOEFFEKT MENTHOLFRISCH’:tn OR ‘CHILDRENS SOLUBLE PARACETAMOL TABLETS’:tn OR ‘CHOLIGRIP’:tn OR ‘CIBALGINA EMICRANIA CEFALEA’:tn OR ‘CINFATÓS’:tn OR ‘CITODON’:tn OR ‘CITRAMON’:tn OR ‘CITRAMONAS’:tn OR

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 15/373

    ‘CITRAMONS FORTE’:tn OR ‘CITROSAN’:tn OR ‘CLARADOL’:tn OR ‘CLARADOL CAFEINE’:tn OR ‘CLEAR DISSOLVING PAIN RELIEF PLUS TABLETS’:tn OR ‘CLEAR DISSOLVING PAIN RELIEF TABLETS’:tn OR ‘CLOCINOL’:tn OR ‘CO CODAMOL’:tn OR ‘COCODAMOL’:tn OR ‘CODYDRAMOL’:tn OR ‘COEFFERALGAN’:tn OR ‘CODEFFERALGAN’:tn OR ‘CODALVONIL’:tn OR ‘CODAMIN P’:tn OR ‘CODAMOL’:tn OR ‘CODANOL’:tn OR ‘CODAXOL’:tn OR ‘CODEINE PHOSPHATEPARACETAMOL’:tn OR ‘CODIPAR’:tn OR ‘CODOFORME’:tn OR ‘CODOLIPRANE’:tn OR ‘CODYDRAMOL’:tn OR ‘COLD & FLU DAY’:tn OR ‘COLD & FLU LEMON’:tn OR ‘COLD & FLU NIGHT’:tn OR ‘COLD AND FLU MAX STRENGTH’:tn OR ‘COLD RELIEF’:tn OR ‘COLD& FLU LEMON FLAVOUR’:tn OR ‘COLDAMIN’:tn OR ‘COLDREX’:tn OR ‘COLDREX JUNIOR’:tn OR ‘COLDREX KTR’:tn OR ‘COLDREX MAXGRIP CITRON’:tn OR ‘COLDRIN’:tn OR ‘COLDVIN’:tn OR ‘COLDY’:tn OR ‘COLDYN MAX STRENGHT’:tn OR ‘COLNIDIN’:tn OR ‘COMBIDOLEX’:tn OR ‘COMBOGESIC’:tn OR ‘COMPRALGYL’:tn OR ‘CONTAC NON DROWSY DUAL RELIEF’:tn OR ‘CONTRANEURAL’:tn OR ‘COPAZ’:tn OR ‘COPYRKAL’:tn OR ‘CORTAFRIOL’:tn OR ‘COULDINA CON PARACETAMOL’:tn OR ‘COULDINA INSTANT CON PARACETAMOL’:tn OR ‘COVONIA COLD & FLU FORMULA’:tn OR ‘COXUMADOL’:tn OR ‘CROIX BLANCHE’:tn OR ‘CURIDOL’:tn OR ‘CÊGRIPE’:tn OR ‘DAFALGAN’:tn OR ‘DAFALGANHOP’:tn OR ‘DALERON’:tn OR ‘DAY & NIGHT NURSE’:tn OR ‘DAY COLD & FLU’:tn OR ‘DAY NURSE’:tn OR ‘DAYMED’:tn OR ‘DEFEBRYL’:tn OR ‘DELPARAN’:tn OR ‘DEPALGOS’:tn OR ‘DEPOFORTE’:tn OR ‘DEPON’:tn OR ‘DIALGON’:tn OR ‘DILIBAN’:tn OR ‘DIOPPEX’:tn OR ‘DOANS’:tn OR ‘DOLURON’:tn OR ‘DOLAN’:tn OR ‘DOLETAM’:tn OR ‘DOLEVAR’:tn OR ‘DOLFLASH’:tn OR ‘DOLI ETAT GRIPPAL’:tn OR ‘DOLI ÉTAT GRIPPAL’:tn OR ‘DOLIPRANE’:tn OR ‘DOLIPRANELIB’:tn OR ‘DOLIPRANEORO’:tn OR ‘DOLIPRANEVITAMINEC’:tn OR ‘DOLIPRO’:tn OR ‘DOLIRHUME’:tn OR ‘DOLIRHUMEPRO PARACETAMOL, PSEUDOEPHEDRINE ET DOXYLAMINE, COMPRIME’:tn OR ‘DOLKO’:tn OR ‘DOLOCATIL’:tn OR ‘DOLOLINSTANT’:tn OR ‘DOLOMEDIL’:tn OR ‘DOLOMO’:tn OR ‘DOLOPYRIN’:tn OR ‘DOLORAMOL’:tn OR ‘DOLOSTOP’:tn OR ‘DOLOVERSA’:tn OR ‘DOLPRONE’:tn OR ‘DOLSTIC’:tn OR ‘DOLUXIO COMBI’:tn OR ‘DOLVAN’:tn OR ‘DOREGRIPPIN’:tn OR ‘DORETA’:tn OR ‘DOZOL’:tn OR ‘DRAY’:tn OR ‘DRILL’:tn OR ‘DUAN’:tn OR ‘DULSIFEB’:tn OR ‘DYPRACET’:tn OR ‘EFETAMOL COMPRIMIDOS’:tn OR ‘EFETAMOL SOLUCIÓN’:tn OR ‘EFFERALGAN’:tn OR ‘EFFERALGANODIS’:tn OR ‘EFFERALGANTAB’:tn OR ‘EFFERALGANVITAMINEC’:tn OR ‘ENELFA’:tn OR ‘ERIFRIN’:tn OR ‘ERKÄLTUNGSGETRÄNK’:tn OR ‘ERKÄLTUNGSSIRUP FÜR DIE NACHT’:tn OR ‘ETOPIRYNA PLUS’:tn OR ‘EXBOL’:tn OR ‘EXCEDITE’:tn OR ‘EXCEDRIN’:tn OR ‘EXCEDRINIL’:tn OR ‘EXCEDRYN’:tn OR ‘EXOPON’:tn OR ‘FARINGO HOT DRINK’:tn OR ‘FASCONAL’:tn OR ‘FASCONAL PRO’:tn OR ‘FEBRECTAL’:tn OR ‘FEBRIDOL’:tn OR ‘FEBRILIN’:tn OR ‘FEBRISAN’:tn OR ‘FENNINGS CHILDRENS’:tn OR ‘FERVEFLU ADULTS SUGARFREE’:tn OR ‘FERVEFLU ANTITUSSIVE’:tn OR ‘FERVEX’:tn OR ‘FIBRALGIN C’:tn OR ‘FIBREX’:tn OR ‘FINEURAL’:tn OR ‘FINIMAL’:tn OR ‘FINIMAL ZEST’:tn OR ‘FLU STRENGTH HOT LEMON’:tn OR ‘FLU TRIPLA AZIONE’:tn OR ‘FLUCONTROL HOT’:tn OR ‘FLUCONTROL MAX’:tn OR ‘FLUENTAL’:tn OR ‘FLUFIX HOT DRINK’:tn OR ‘FLUIMUCIL COMPLEX’:tn OR ‘FLUIMUCIL INFLUENZA E RAFFREDDORE’:tn OR ‘FLUMIN’:tn OR ‘FLUNATHAN’:tn OR ‘FLUSTIMEX’:tn OR ‘FORTAMOL’:tn OR ‘FOXIS’:tn OR ‘FRENADOL’:tn OR ‘FRIALGINA’:tn OR ‘FRICOLD’:tn OR ‘GAOSEDAL CODEINE’:tn OR ‘GELOCATIL’:tn OR ‘GELONIDA SCHMERZTABLETTEN’:tn OR ‘GELOPROM’:tn OR ‘GELOPROMT’:tn OR ‘GELOPROSED’:tn OR ‘GELUPRANE’:tn OR ‘GEMIPAR’:tn OR ‘GEWADALPAMOL’:tn OR ‘GRIPAVICKS’:tn OR ‘GRIPEX’:tn OR ‘GRIPOFLEKS 500’:tn OR ‘GRIPOFLEKS 750’:tn OR ‘GRIPONAL’:tn OR ‘GRIPOSTOP’:tn OR ‘GRIPPAL+C ’:tn OR ‘GRIPPEX’:tn OR ‘GRIPPOMED’:tn OR ‘GRIPPOSTAD’:tn OR ‘GRYPOLEK’:tn OR ‘GRYPOSTOP’:tn OR ‘HATABLETTEN N GEGEN SCHMERZEN’:tn OR ‘HEADACHE AND INDIGESTION RELIEF’:tn OR ‘HEADACHE RELIEF’:tn OR ‘HEDEX’:tn OR ‘HEMA KINDERPARACETAMOL ZETPIL HEMA’:tn OR ‘HEMICRANEAL’:tn OR ‘HIBIGRIPAL’:tn OR ‘HIPATRA REGIST’:tn OR ‘HOOFDPIJNPOEDERS’:tn OR ‘HOT BLACKCURRANT COLD RELIEF’:tn OR ‘HOT COLDREX’:tn OR ‘HOT LEMON COLD RELIEF’:tn OR ‘HOTMAX’:tn OR ‘HOTRIMOX’:tn OR ‘HUMAGRIP’:tn OR ‘HUMEX COLD’:tn OR ‘HUMEX RHUME’:tn OR ‘HUMEXGRIP’:tn OR ‘HUMEXLIB’:tn OR ‘HUMEXLIB

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 16/373

    ETAT GRIPPAL’:tn OR ‘IBUEM’:tn OR ‘IBUPAROL’:tn OR ‘IBUPROFEN AND PARACETAMOL’:tn OR ‘IDYL KINDERPARACETAMOL’:tn OR ‘IDYL PARACETAMOL’:tn OR ‘IDYL PARACETAMOLCOFFEINE SDG FARMA’:tn OR ‘INFLUASS’:tn OR ‘INFLUBENE’:tn OR ‘INFLUCUP’:tn OR ‘INFLUDEX’:tn OR ‘INFLUENZA E RAFFREDDORE’:tn OR ‘INFLUMED’:tn OR ‘INFLUVIT’:tn OR ‘IROCOPHAN’:tn OR ‘IXPRIM’:tn OR ‘IZALGI’:tn OR ‘JUMBO KINDERPARACETAMOL’:tn OR ‘JUMBO PARACETAMOL’:tn OR ‘KAPAKE’:tn OR ‘KIDOFEN DUO’:tn OR ‘KINDERPARACETAMOL’:tn OR ‘KLIPAL CODEINE’:tn OR ‘KODIPAR’:tn OR ‘KOFIDEC’:tn OR ‘KOLIBRI’:tn OR ‘KOMBI ERKÄLTUNGSGETRÄNK’:tn OR ‘KORYLAN’:tn OR ‘KRUIDVAT’:tn OR ‘KRUIDVAT PARACETAMOL’:tn OR ‘LAFOR’:tn OR ‘LAMALINE’:tn OR ‘LEIDAPHARM APC’:tn OR ‘LEIDAPHARM KINDERPARACETAMOL’:tn OR ‘LEIDAPHARM PARACETAMOL’:tn OR ‘LEKADOL’:tn OR ‘LEKADOR’:tn OR ‘LEM PLUS’:tn OR ‘LEM PLUSHOT LEMON’:tn OR ‘LEMON COLDREX’:tn OR ‘LEMSIP’:tn OR ‘LIATAMOLO’:tn OR ‘LINDILANE’:tn OR ‘LINEROL’:tn OR ‘LISOFLU’:tn OR ‘LISOPAN’:tn OR ‘LLVICO’:tn OR ‘LONALGAL’:tn OR ‘LONARID’:tn OR ‘LUPOCET’:tn OR ‘LUPRATRAC’:tn OR ‘MANDANOL’:tn OR ‘MANN’:tn OR ‘MARANZA’:tn OR ‘MAX STRENGTH COLD & FLU LEMON FLAVOUR’:tn OR ‘MAXFLU’:tn OR ‘MAXILIEF’:tn OR ‘MEDICOLDAX’:tn OR ‘MEDINAIT’:tn OR ‘MEDINITE’:tn OR ‘MEDINITE COMPLETE’:tn OR ‘MEDINITE SIRUP’:tn OR ‘MEDINOL’:tn OR ‘MEDRACET’:tn OR ‘MELABON’:tn OR ‘METAFEN’:tn OR ‘MEXAVIT.C’:tn OR ‘MEXALEN’:tn OR ‘MIGRAEFLUX MCP’:tn OR ‘MIGRALAVE + MCP’:tn OR ‘MIGRALEVE’:tn OR ‘MIGRALEVE YELLOW’:tn OR ‘MIGRALGIN’:tn OR ‘MIGRALGINE’:tn OR ‘MIGRETIL’:tn OR ‘MIGRÄNENEURIDAL’:tn OR ‘MINDELHEIMER KOPFSCHMERZ’:tn OR ‘MIPYRIN’:tn OR ‘MIRALGN TABL’:tn OR ‘MOBISTIX FORTE INSTANT’:tn OR ‘MOBISTIX INSTANT’:tn OR ‘MOBISTIX JUNIOR INSTANT’:tn OR ‘MODAFEN HOT DRINK’:tn OR ‘MONO PRAECIMED’:tn OR ‘MYLORAMOL’:tn OR ‘NPARACETAMOL’:tn OR ‘NEALGIN’:tn OR ‘NEDAC SORBO KINDERPARACETAMOL’:tn OR ‘NEO BOROCILLINA’:tn OR ‘NEO BOROCILLINA RAFFREDDORE E FEBBRE’:tn OR ‘NEO CITRAN’:tn OR ‘NEO NEVRAL’:tn OR ‘NEO NISIDINA’:tn OR ‘NEOCIBALGINA’:tn OR ‘NEONISIDINA C’:tn OR ‘NEOOPTALIDON’:tn OR ‘NEOASKOFENAS’:tn OR ‘NEOCITRAMONAS’:tn OR ‘NEOGRIP’:tn OR ‘NEROZILA’:tn OR ‘NEURALGIN’:tn OR ‘NEURANIDAL N SCHMERZTABLETTEN’:tn OR ‘NEVRALMED’:tn OR ‘NIGHT COLD & FLU RELIEF’:tn OR ‘NIGHT NURSE’:tn OR ‘NIGHT NURSE COLD REMEDY’:tn OR ‘NIGHT NURSE HOT LEMON MENTHOL’:tn OR ‘NIOCITRAN’:tn OR ‘NIROLEX FEBBRE E DOLORE’:tn OR ‘NIROLEX FLU TRIPLA AZIONE’:tn OR ‘NOSPALGIN’:tn OR ‘NOALGA’:tn OR ‘NONDROWSY SINUTAB’:tn OR ‘NONDROWSY SUDAPLUS’:tn OR ‘NORGESIC’:tn OR ‘NORMAFLU’:tn OR ‘NUROFEN ULTIMA’:tn OR ‘NUROMOL’:tn OR ‘NYGEN’:tn OR ‘OCTADON P’:tn OR ‘OKALGRIP’:tn OR ‘OLASKOFĒNS’:tn OR ‘OLCITRAMONS’:tn OR ‘OPTALIDON’:tn OR ‘OPTIPYRIN’:tn OR ‘PABIALGIN NEO’:tn OR ‘PACET’:tn OR ‘PADEVIX’:tn OR ‘PADOLIEVE’:tn OR ‘PADOLIEVE MAX’:tn OR ‘PADOLTEN’:tn OR ‘PAEDIALGON’:tn OR ‘PAIN RELIEF’:tn OR ‘PALGOTAL’:tn OR ‘PAMOL’:tn OR ‘PAMOLHOTC’:tn OR ‘PANACOD’:tn OR ‘PANADEINE’:tn OR ‘PANADOL’:tn OR ‘PANADOL BABY’:tn OR ‘PANADOL EXTRA’:tn OR ‘PANADOL MAX’:tn OR ‘PANADOL PLUS’:tn OR ‘PANAGRAM MAX’:tn OR ‘PANASORBE’:tn OR ‘PANCONTRA’:tn OR ‘PANOCOD’:tn OR ‘PANODIL’:tn OR ‘PANODOL FORTE’:tn OR ‘PANONEO’:tn OR ‘PANTADOLOR’:tn OR ‘PAPCO’:tn OR ‘PAPHADEX COMBI’:tn OR ‘PARACAF’:tn OR ‘PARAHOT’:tn OR ‘PARASUPPO’:tn OR ‘PARATABS’:tn OR ‘PARACEDOL’:tn OR ‘PARACEON’:tn OR ‘PARACET’:tn OR ‘PARACETA’:tn OR ‘PARACETAMAX’:tn OR ‘PARACETAMOL’:tn OR ‘PARACETAMOL+TRAMADOL MEPHA’:tn OR ‘PARACETAMOL, CAFEINA FARMEX’:tn OR ‘PARACETAMOL, CODEINE AND CAFFEINE’:tn OR ‘PARACETAMOLPHENYLEPHRINE HYDROCHLORIDE POWDER’:tn OR ‘PARACETAMOL’:tn OR ‘PARACETAMOLTRAMADOL HCL ’:tn OR ‘PARACETAMOLASPIRINCAFFEINE WOCKHARDT UK LTD’:tn OR ‘PARACETAMOLASSCOFFEIN KOPFSCHMERZ & MIGRÄNE’:tn OR ‘PARACETAMOLCAFFEINE WOCKHARDT UK LTD’:tn OR ‘PARACETAMOLCAFFEINEPHENYLEPHRINE HYDROCHLORIDE WOCKHARDT UK LTD’:tn OR ‘PARACETAMOLCAFFEINEPHENYLEPHRINE’:tn OR ‘PARACETAMOLCHLORPHENAMINE URGO’:tn OR ‘PARACETAMOLCODEIN’:tn OR ‘PARACETAMOLCODEINE’:tn OR ‘PARACETAMOLCODEÍNA’:tn OR ‘PARACETAMOLCOFFEINE’:tn OR

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 17/373

    ‘PARACETAMOLCOFFEÏNE’:tn OR ‘PARACETAMOLKODEIN’:tn OR ‘PARACETAMOLKODEIN’:tn OR ‘PARACETAMOLKODEIN EVOLAN’:tn OR ‘PARACETAMOLPHENYLEPHRINE’:tn OR ‘PARACETAMOLPHENYLEPHRINE HYDROCHLORID’:tn OR ‘PARACETAMOLPOUDRE DOPIUM’:tn OR ‘PARACETAMOLPROMETHAZINE HYDROCHLORIDEDEXTROMETHORPHAN HYDROBROMIDE’:tn OR ‘PARACETAMOLVITAMINE’:tn OR ‘PARACETAMOLO’:tn OR ‘PARACETDUO’:tn OR ‘PARACETOL’:tn OR ‘PARACOD’:tn OR ‘PARACODOL’:tn OR ‘PARACOF’:tn OR ‘PARACOFDAL’:tn OR ‘PARACUT’:tn OR ‘PARADOLOR CAPPUCCINOGESCHMACK’:tn OR ‘PARADOLOR ERDBEERVANILLE’:tn OR ‘PARADOREN’:tn OR ‘PARAEXTRA’:tn OR ‘PARAFLUDETEN’:tn OR ‘PARAFLUX’:tn OR ‘PARAFUSE’:tn OR ‘PARAFUSIV’:tn OR ‘PARAGRIP C’:tn OR ‘PARALEN’:tn OR ‘PARALEN SUS’:tn OR ‘PARALGAM’:tn OR ‘PARALGAME’:tn OR ‘PARALGIL’:tn OR ‘PARALIEF’:tn OR ‘PARALINK’:tn OR ‘PARALYOC’:tn OR ‘PARAMAX’:tn OR ‘PARAMAXCOD’:tn OR ‘PARAMEGAL’:tn OR ‘PARAMOL’:tn OR ‘PARAMOLAN’:tn OR ‘PARAMOLAN C’:tn OR ‘PARAPHAR’:tn OR ‘PARASINUS’:tn OR ‘PARASINUS PENTA’:tn OR ‘PARASOLVE MAX’:tn OR ‘PARATABS’:tn OR ‘PARATABS’:tn OR ‘PARATRAM’:tn OR ‘PARATRAMOL’:tn OR ‘PARCODIN’:tn OR ‘PARCOTEN’:tn OR ‘PARECETAMOLCAFFEINEPHENYLEPHRINE HYDROCHLORIDE’:tn OR ‘PARKÓDÍN’:tn OR ‘PARSEL’:tn OR ‘PARSELC’:tn OR ‘PARSELS’:tn OR ‘PARTRAMEC’:tn OR ‘PATROL’:tn OR ‘PAZITAL’:tn OR ‘PCMHEMOPHARM’:tn OR ‘PETAM’:tn OR ‘PEDICETAMOL’:tn OR ‘PERDOLAN’:tn OR ‘PERFALGAN’:tn OR ‘PERFALGAN POLYPROPYLENE BAG’:tn OR ‘PERIOD PAIN RELIEF’:tn OR ‘PHARMAGRIP’:tn OR ‘PINEMOL’:tn OR ‘PINEX’:tn OR ‘PIRALDOL’:tn OR ‘PIRANTAMOL’:tn OR ‘PIRESTOP’:tn OR ‘PIROS’:tn OR ‘PLICET’:tn OR ‘PLIVADON’:tn OR ‘PLIVAMED’:tn OR ‘POCKETPAK’:tn OR ‘POLTRAM COMBO’:tn OR ‘PONTALSIC’:tn OR ‘POWDER FOR ORAL SOLUTION’:tn OR ‘PPC’:tn OR ‘PR’:tn OR ‘PREST’:tn OR ‘PRIMACARE COLD & FLU RELIEF LEMON POWDER’:tn OR ‘PRONTALGINE’:tn OR ‘PROPAIN PLUS’:tn OR ‘PROPALGINA PLUS’:tn OR ‘PROPYFENAZON COMP.’:tn OR ‘PROTALGON’:tn OR ‘PUERIFLU’:tn OR ‘QURAMOL’:tn OR ‘RACETIC’:tn OR ‘RAFFREDDOREMED’:tn OR ‘RAMPAR’:tn OR ‘RATIOGRIP’:tn OR ‘RATIOPYRIN’:tn OR ‘REMEDEINE’:tn OR ‘REMEDOL’:tn OR ‘RENLAUCOL’:tn OR ‘RESFRIVICKS’:tn OR ‘RESOLVEBOHM’:tn OR ‘RETORTAPYRIN’:tn OR ‘RHINOFEBRYL’:tn OR ‘RHINOSTOP’:tn OR ‘RHUMAGRIP’:tn OR ‘ROBAXISAL COMPUESTO’:tn OR ‘ROLOD’:tn OR ‘ROTER APC’:tn OR ‘ROTER PARACETAMOL’:tn OR ‘ROWALIEF’:tn OR ‘ROWASIP COLD & FLU WITH DECONGESTANT’:tn OR ‘ROWASIP MAX STRENGTH COLD & FLU WITH DECONGESTANT’:tn OR ‘RUBOPHEN’:tn OR ‘SANADOR’:tn OR ‘SANALGIN’:tn OR ‘SANIDUO FEBBRE E NASO CHIUSO’:tn OR ‘SANIPIRINA’:tn OR ‘SARIDON’:tn OR ‘SEDALGIN NEO’:tn OR ‘SEDARENE’:tn OR ‘SEDIS’:tn OR ‘SEDOLORIS’:tn OR ‘SERRAGRIP’:tn OR ‘SIGAMOL’:tn OR ‘SINEBRIV FEBBRE E DOLORE’:tn OR ‘SINEGRIP’:tn OR ‘SINPRO’:tn OR ‘SINUTAB’:tn OR ‘SINUTABFORTE’:tn OR ‘SNIP’:tn OR ‘SOLFLU’:tn OR ‘SOLPASINUS’:tn OR ‘SOLPADEINE’:tn OR ‘SOLPADOL’:tn OR ‘SOLUBLE CUPANOL LEMON FLAVOUR’:tn OR ‘SOLUCIÓN ORAL’:tn OR ‘SOLVONGRIP’:tn OR ‘SOOTHEZE PLUS’:tn OR ‘SPASMOPAN’:tn OR ‘STASIPARA’:tn OR ‘STRENDUO’:tn OR ‘SUDAFED DECONGESTANT & PAIN’:tn OR ‘SUPOFEN’:tn OR ‘SURBRONC ETAT GRIPPAL’:tn OR ‘SWISPARA’:tn OR ‘SYMPTOMED’:tn OR ‘SYMTRAM’:tn OR ‘SYNDOL’:tn OR ‘TABCIN TREND’:tn OR ‘TABLETTA ANTIDOLORICA’:tn OR ‘TACHICAF’:tn OR ‘TACHIDOL’:tn OR ‘TACHIFENE’:tn OR ‘TACHIFLUDEC’:tn OR ‘TACHIFLUDEC GUSTO LIMONE’:tn OR ‘TACHINOTTE’:tn OR ‘TACHIPIRIN’:tn OR ‘TACHIPIRINA’:tn OR ‘TACHIPIRINAFLU’:tn OR ‘TACHIVERDE’:tn OR ‘TAKIPIRINA’:tn OR ‘TALVOSILEN’:tn OR ‘TAMOCHIR’:tn OR ‘TEEDEX’:tn OR ‘TEMAGIN PAC’:tn OR ‘TEMAGIN PARACETAMOL PLUS’:tn OR ‘TEMPIDOL’:tn OR ‘TERMADEC’:tn OR ‘TERMALDINA’:tn OR ‘TERMALGIN’:tn OR ‘TERMANASAL’:tn OR ‘TERMOL’:tn OR ‘TESCO’:tn OR ‘GRIP’:tn OR ‘TEVITAMOL’:tn OR ‘THEINOL’:tn OR ‘THERACOMPLEX ERKÄLTUNG & HUSTEN’:tn OR ‘THERAFLU’:tn OR ‘THERAPEUTICON’:tn OR ‘THERIMIN’:tn OR ‘THOMAPYRIN’:tn OR ‘TIALGIN’:tn OR ‘TITRALGAN GEGEN SCHMERZEN’:tn OR ‘TITRETTA’:tn OR ‘TITRETTA SCHMERZTABLETTEN’:tn OR ‘TOGAL CLASSIC DUO’:tn OR ‘TOGAL KOMBI’:tn OR ‘TOMAKET’:tn OR ‘TOMASS’:tn OR ‘TOMIN’:tn OR ‘TONYPIRYN’:tn OR ‘TOPLEXIL’:tn OR ‘TRACEMOL’:tn OR ‘TRACIMOL’:tn OR ‘TRALZARO VENIPHARM’:tn

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 18/373

    OR ‘TRAMABIAN’:tn OR ‘TRAMACET’:tn OR ‘TRAMADOL + PARACETAMOL’:tn OR ‘TRAMADOL PARACETAMOL’:tn OR ‘TRAMADOL HCLPARACETAMOL’:tn OR ‘TRAMADOL HYDROCHLORIDE PARACETAMOL FILMCOATED TABLET’:tn OR ‘TRAMADOL HYDROCHLORIDE AND PARACETAMOL DAWA’:tn OR ‘TRAMADOL HYDROCHLORIDEPARACETAMOL’:tn OR ‘TRAMADOL PARACETAMOL’:tn OR ‘TRAMADOL PARACETAMOL’:tn OR ‘TRAMADOLHYDROCHLORIDPARACETAMOL’:tn OR ‘TRAMADOLOR PLUS’:tn OR ‘TRAMADOX’:tn OR ‘TRAMAPAR’:tn OR ‘TRAMAPRAM’:tn OR ‘TRAMAPRAN’:tn OR ‘TRAMCET’:tn OR ‘TRAMPALGIN’:tn OR ‘TRAMYLPA’:tn OR ‘TRAPAR’:tn OR ‘TRAUMOBOL’:tn OR ‘TREKPLEISTER APC’:tn OR ‘TREKPLEISTER KINDERPARACETAMOL’:tn OR ‘TREKPLEISTER PARACETAMOL’:tn OR ‘TREKPLEISTER PARACETAMOL MET COFFEINE’:tn OR ‘TRIACTIN’:tn OR ‘TRIACTIN COMPLETE’:tn OR ‘TRIAMINIC’:tn OR ‘TRIFLU’:tn OR ‘TRIFLUNEX’:tn OR ‘TRIGAN D’:tn OR ‘TRIMEDIC’:tn OR ‘TRIMEDIL’:tn OR ‘TRINELL PRO’:tn OR ‘TROC’:tn OR ‘TROPHIRES COMPOSE’:tn OR ‘TUTUS’:tn OR ‘TYLENOL’:tn OR ‘TYLEX’:tn OR ‘TYLEX, MEDOCODENE’:tn OR ‘ULTRACOD’:tn OR ‘ULTRAMOL’:tn OR ‘UNAFLUX’:tn OR ‘UNEBRIL’:tn OR ‘UNIFLU’:tn OR ‘VALCOMB’:tn OR ‘VALETOL’:tn OR ‘VEGANIN’:tn OR ‘VERAMON’:tn OR ‘VETOPAR’:tn OR ‘VICKS ACTIVE MAX’:tn OR ‘VICKS LĂMÂIE’:tn OR ‘VICKS SYMPTOMED CLASSIC CITRÓN’:tn OR ‘VINCIGRIP’:tn OR ‘VIRALKEY’:tn OR ‘VIVIMED’:tn OR ‘VIVIMED MIT COFFEIN GEGEN KOPFSCHMERZEN’:tn OR ‘VIVIMED N GEGEN FIEBER UND KOPFSCHMERZEN’:tn OR ‘VLOEIBAAR VOOR KINDEREN’:tn OR ‘WEGMAL’:tn OR ‘WITTE KRUIS’:tn OR ‘XUMADOL’:tn OR ‘XUMADOL COMPRIMIDOS’:tn OR ‘XUMADOL GRANULADO’:tn OR ‘XYMEL COMP’:tn OR ‘YENDOL’:tn OR ‘ZALDIAR’:tn OR ‘ZAPAIN’:tn OR ‘ZARACET’:tn OR ‘ZEGLIO’:tn OR ‘ZERINOL’:tn OR ‘ZERINOLFLU’:tn OR ‘ZEUSEFF’:tn OR ‘ZILPEN’:tn OR ‘ZOTRAMID’:tn OR ‘ABENOL’:tn OR ‘ACAMOL’:tn OR ‘ACENOL’:tn OR ‘ACEPHEN’:tn OR ‘ACET’:tn OR ‘ACETA’:tn OR ‘ACETALGIN’:tn OR ‘ACETAMINOPHEN’:tn OR ‘ACETAMOL’:tn OR ‘ACTIFED’:tn OR ‘ACTRON’:tn OR ‘ACURATE’:tn OR ‘ADALGUR’:tn OR ‘ADCODOL’:tn OR ‘ADCOSINAL CO’:tn OR ‘ADINOL’:tn OR ‘ADOL’:tn OR ‘ALAXAN’:tn OR ‘ALGITRIN’:tn OR ‘ALGOCOD’:tn OR ‘ALKASELTZER PLUS’:tn OR ‘ALKASELTZER PLUSD MULTISYMPTOM SINUS AND COLD’:tn OR ‘ALPINY’:tn OR ‘ALVEDON’:tn OR ‘ANACIN ASPIRIN FREE’:tn OR ‘ANADIN’:tn OR ‘ANADIN EXTRA’:tn OR ‘ANAGRAINE’:tn OR ‘ANALGAN’:tn OR ‘ANALGAN EXTRA’:tn OR ‘ANAREX’:tn OR ‘ANHIBA’:tn OR ‘ANTIDOL’:tn OR ‘ANTIGRIPAL’:tn OR ‘ANTIGRIPPIN’:tn OR ‘ANYRUME’:tn OR ‘APAP’:tn OR ‘APC’:tn OR ‘APOTRAMADOLACET’:tn OR ‘ARTHRITIS PAIN RELIEVER’:tn OR ‘ATASOL FORTE’:tn OR ‘ATMIPHEN’:tn OR ‘AZUR’:tn OR ‘BECETAMOL’:tn OR ‘BENURON’:tn OR ‘BENADRYL TOTAL’:tn OR ‘BENYLIN’:tn OR ‘BERAMOL’:tn OR ‘BETAPYN’:tn OR ‘BIOGESIC’:tn OR ‘BUCKLEYS COMPLETE EXTRA STRENGTH COUGH, COLD AND FLU NIGHT’:tn OR ‘BUCKLEYS COMPLETE NIGHTTIME’:tn OR ‘BUSCAPINA COMPOSITUM N’:tn OR ‘BUSCODUO’:tn OR ‘BUSCOPAN COMPOSITUM’:tn OR ‘BUSCOPAN PLUS’:tn OR ‘CAFFETIN’:tn OR ‘CALONAL’:tn OR ‘CALPOL’:tn OR ‘CALSIL’:tn OR ‘CAPITAL & CODEINE’:tn OR ‘CAPTIN’:tn OR ‘CEFECON D’:tn OR ‘CETAMOL’:tn OR ‘CHILDRENS PANADOL’:tn OR ‘CHILDRENS PARACETAMOL’:tn OR ‘CHILDRENS TYLENOL’:tn OR ‘CHILDRENS TYLENOL’:tn OR ‘CIBALENA A’:tn OR ‘CITRAMON’:tn OR ‘CITROSAN’:tn OR ‘CLARADOL’:tn OR ‘COBECETAMOL’:tn OR ‘COCODAMOL’:tn OR ‘CODAFALGAN’:tn OR ‘CODYDRAMOL’:tn OR ‘COEFFERALGAN’:tn OR ‘COTYLENOL’:tn OR ‘COCARL’:tn OR ‘CODEFFERALGAN’:tn OR ‘CODALGIN’:tn OR ‘CODAMOL’:tn OR ‘CODAPANE’:tn OR ‘CODOLIPRANE’:tn OR ‘COLDEX’:tn OR ‘COLDREX’:tn OR ‘COLDREX HOTREM’:tn OR ‘COLNIDIN’:tn OR ‘COMTREX’:tn OR ‘CORICIDIN HBP’:tn OR ‘CURADON’:tn OR ‘CURIDOL’:tn OR ‘DAFALGAN’:tn OR ‘DATRIL’:tn OR ‘DAYQUIL’:tn OR ‘DECOLGEN’:tn OR ‘DEXAMOL’:tn OR ‘DIMETAPP NIGHTIME’:tn OR ‘DISPROL’:tn OR ‘DOLCET’:tn OR ‘DOLGESIC’:tn OR ‘DOLIPRANE’:tn OR ‘DOLIRHUME’:tn OR ‘DOLO’:tn OR ‘DOLO650’:tn OR ‘DOLOFRIX’:tn OR ‘DOLOROL’:tn OR ‘DOLOSTOP’:tn OR ‘DOLPRONE’:tn OR ‘DOLTRAMCET’:tn OR ‘DORICO’:tn OR ‘DOZOL’:tn OR ‘DRISTAN COLD MULTISYMPTOM’:tn OR ‘DRISTAN EXTRA STRENGTH’:tn OR ‘DUATROL SR’:tn OR ‘DUMIN’:tn OR ‘DYMADON’:tn OR ‘DYMADON P’:tn OR ‘EFFERALGAN’:tn OR ‘EMPAPED’:tn OR ‘EMPRACET’:tn OR ‘EMTEC30’:tn OR ‘ENDOCET’:tn OR

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 19/373

    ‘EQUATE’:tn OR ‘EQUATE ARTHRITIS PAIN’:tn OR ‘EQUATE DAY TIME COLD AND FLU MULTI SYMPTOM RELIEF’:tn OR ‘EQUATE PAIN RELIEVER EXTRA STRENGTH’:tn OR ‘EUROPAIN’:tn OR ‘EXCEDRIN’:tn OR ‘EXCEDRYN’:tn OR ‘EXEDRIN’:tn OR ‘EXTRA STRENGTH QPAP’:tn OR ‘EXTRA STRENGTH TYLENOL’:tn OR ‘FEBRECTOL’:tn OR ‘FEBRICET’:tn OR ‘FEBRIDOL’:tn OR ‘FECOL’:tn OR ‘FEMINAX’:tn OR ‘FERVEX’:tn OR ‘FEVERALL’:tn OR ‘FINEURAL’:tn OR ‘FINIMAL’:tn OR ‘FLUIMUCIL GRIPPE DAY & NIGHT’:tn OR ‘FLUTEX’:tn OR ‘FRENADOL’:tn OR ‘GERALGINEK’:tn OR ‘GOODYS EXTRA STRENGTH’:tn OR ‘GOODYS’:tn OR ‘GRIPEX’:tn OR ‘HEDEX’:tn OR ‘ILVICO’:tn OR ‘INFANTS CONCENTRATED TYLENOL’:tn OR ‘INFANTS TYLENOL’:tn OR ‘IXPRIM’:tn OR ‘JAMPACETTRAMADOL’:tn OR ‘KLIPAL’:tn OR ‘KLIPAL CODEINE’:tn OR ‘LEKADOL’:tn OR ‘LEMSIP’:tn OR ‘LINDILANE’:tn OR ‘LONARID’:tn OR ‘MAGNACET’:tn OR ‘MAPAP’:tn OR ‘MAPAP ARTHRITIS PAIN’:tn OR ‘MEDINITE’:tn OR ‘MERSYNDOL DAYSTRENGTH’:tn OR ‘METOMAX’:tn OR ‘MEXALEN’:tn OR ‘MIDOL’:tn OR ‘MIGRAINE FORMULA’:tn OR ‘MIGRALEVE’:tn OR ‘MIGRALGINE’:tn OR ‘MINOSET PLUS’:tn OR ‘MIOCITALGAN’:tn OR ‘MOMENTUM’:tn OR ‘MUCINEX FASTMAX COLD AND SINUS’:tn OR ‘MUSCOL’:tn OR ‘MYPAID’:tn OR ‘MYPAID FORTE’:tn OR ‘NAPA’:tn OR ‘NAPACOD’:tn OR ‘NARON’:tn OR ‘NEO CITRAN’:tn OR ‘NEOCITRAN’:tn OR ‘NEOPYRIN’:tn OR ‘NEOSEC’:tn OR ‘NEOZEP’:tn OR ‘NEURALGIN’:tn OR ‘NONASPIRIN’:tn OR ‘NOREL SR’:tn OR ‘NORFLEX PLUS’:tn OR ‘NORGESIC’:tn OR ‘NOVO PETRIN’:tn OR ‘NOVOGESIC’:tn OR ‘NYQUIL COLD AND FLU’:tn OR ‘NYQUIL D COLD AND FLU NIGHTTIME RELIEF’:tn OR ‘OFIRMEV’:tn OR ‘ORKELAX’:tn OR ‘OXYCOCET’:tn OR ‘OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN WATSON’:tn OR ‘PACIMOL’:tn OR ‘PACOFEN’:tn OR ‘PAIN RELIEF’:tn OR ‘PAIN RELIEVER PM’:tn OR ‘PAINAMOL’:tn OR ‘PAINBLOK’:tn OR ‘PAINSTOP’:tn OR ‘PAMOL’:tn OR ‘PANACOD’:tn OR ‘PANADEINE’:tn OR ‘PANADO’:tn OR ‘PANADOL’:tn OR ‘PANADOL BABY’:tn OR ‘PANADOL COLD & FLU’:tn OR ‘PANADOL EXTRA’:tn OR ‘PANALGINE’:tn OR ‘PANAMAX’:tn OR ‘PANOCOD’:tn OR ‘PANODIL’:tn OR ‘PARACET’:tn OR ‘PARACETAMOL CODEINE’:tn OR ‘PARACETAMOLCODEINEFOSFAAT’:tn OR ‘PARACETAMOLCODEÏNEFOSFAAT’:tn OR ‘PARACETOL’:tn OR ‘PARACOD’:tn OR ‘PARACODE’:tn OR ‘PARACODOL’:tn OR ‘PARADOL’:tn OR ‘PARALGIN’:tn OR ‘PARALYOC’:tn OR ‘PARAMAX’:tn OR ‘PARAMED’:tn OR ‘PARAMOL’:tn OR ‘PARATRAM’:tn OR ‘PCM’:tn OR ‘PETAM’:tn OR ‘PEDIATRIX’:tn OR ‘PERCOCET’:tn OR ‘PERFALGAN’:tn OR ‘PERFUSALGAN’:tn OR ‘PINEX’:tn OR ‘PRETUVAL’:tn OR ‘PRIMLEV’:tn OR ‘PROCET’:tn OR ‘PRODEINE’:tn OR ‘PROGESIC’:tn OR ‘PROLIEF’:tn OR ‘PYNSTOP’:tn OR ‘PYRINAZIN’:tn OR ‘RAPID RELEASE PAIN RELIEVER’:tn OR ‘RAPIDOL’:tn OR ‘RATIOLENOLTEC’:tn OR ‘RATIOOXYCOCET’:tn OR ‘RELIV’:tn OR ‘REMEDEINE’:tn OR ‘RESFEDRYL’:tn OR ‘RESFENOL’:tn OR ‘RIBER’:tn OR ‘RINUTAN’:tn OR ‘RIVACOCET’:tn OR ‘ROBAXIFEN’:tn OR ‘ROBAXISAL COMPUESTO’:tn OR ‘ROKACET’:tn OR ‘ROXICET’:tn OR ‘SANMOL’:tn OR ‘SARA COLD PS’:tn OR ‘SARIDON’:tn OR ‘SARUTU’:tn OR ‘SEDALMERCK’:tn OR ‘SETAMOL’:tn OR ‘SG’:tn OR ‘SINASPRIL’:tn OR ‘SINE OFF’:tn OR ‘SINUMAX ALLERGY SINUS’:tn OR ‘SINUS RELIEF’:tn OR ‘SINUTAB’:tn OR ‘SOLPADEINE’:tn OR ‘SOLPADOL’:tn OR ‘SONRIDOR’:tn OR ‘SPALT’:tn OR ‘SPECTRAPAIN’:tn OR ‘STONA COLD’:tn OR ‘STOPAIN’:tn OR ‘SUDAFED COLD AND COUGH EXTRA STRENGTH’:tn OR ‘SUDAFED HEAD COLD & SINUS EXTRA STRENGTH’:tn OR ‘SUDAFED PE PRESSURE PLUS PAIN’:tn OR ‘SUDAFED PE PRESSURE PLUS PAIN PLUS COUGH’:tn OR ‘SUDAFED SINUS + ALLERGY & PAIN RELIEF’:tn OR ‘SUNITON’:tn OR ‘SUPADOL’:tn OR ‘SUPRACALM’:tn OR ‘SYNDOL’:tn OR ‘TACHIPIRINA’:tn OR ‘TAFIROL’:tn OR ‘TAMINOL’:tn OR ‘TAMOL’:tn OR ‘TEEN MIDOL COMPLETE’:tn OR ‘TEMPRA’:tn OR ‘TERMALGIN’:tn OR ‘TERMOFREN’:tn OR ‘THERAFLU’:tn OR ‘THOMAPYRIN’:tn OR ‘TIFFY’:tn OR ‘TRAMACET’:tn OR ‘TRAMADOLACET’:tn OR ‘TRAMADOLACETAMINOPHEN ’:tn OR ‘TRAMCET’:tn OR ‘TRAMIL’:tn OR ‘TREZIX’:tn OR ‘TRIAMINIC’:tn OR ‘TRIATEC30’:tn OR ‘TRIMOL’:tn OR ‘TYLENOL’:tn OR ‘TYLENOL SINUS’:tn OR ‘TYLENOL WITH CODEINE’:tn OR ‘TYLEX’:tn OR ‘TYLOL’:tn OR ‘TYLOX’:tn OR ‘ULTRACET’:tn OR ‘VEGANIN’:tn OR ‘VERAMON’:tn OR ‘VERMIDON’:tn OR ‘VICKS DAYQUIL SINUS’:tn OR ‘VICKS FORMULA 44M’:tn OR ‘VICKS NYQUIL COLD AND FLU’:tn OR ‘VOPAC’:tn OR ‘WINADOL’:tn OR ‘XOLOX’:tn OR ‘ZALDIAR’:tn OR ‘ZARACET’:tn OR ‘ZENOL’:tn OR ‘ZOLBEN’:tn

  • Monitoring of medical literature and the entry of relevant information into the EudraVigilance database by the European Medicines Agency

    EMA/517840/2015 Effective date: 1 October 2015

    Page 20/373

    AND ('adverse drug reaction'/exp OR adverse:de,ab,ti OR 'side effect':de,ab,ti OR 'side effects':de,ab,ti OR 'side effect':lnk OR 'drug overdose'/exp OR overdos*:de,ab,ti OR 'drug misuse'/exp OR misus*:de,ab,ti OR 'drug abuse'/exp OR 'substance abuse'/exp OR abus*:de,ab,ti OR 'pregnancy'/exp OR pregnan*:de,ab,ti OR 'pregnancy complications'/exp OR 'lactation'/exp OR 'breast feeding'/exp OR ('milk human'/exp AND 'secretion'/e


Recommended